gms | German Medical Science

23rd Annual Meeting of the German Retina Society

German Retina Society

24.09. - 25.09.2010, Freiburg

Ophthalmological therapy in pregnancy

Meeting Abstract

Search Medline for

  • Thomas Neß - University Eye Clinic Freiburg i. Br.

German Retina Society. 23rd Annual Conference of the German Retina Society. Freiburg i. Br., 24.-25.09.2010. Düsseldorf: German Medical Science GMS Publishing House; 2010. Doc10rg22

DOI: 10.3205/10rg22, URN: urn:nbn:de:0183-10rg228

This is the translated version of the article.
The original version can be found at: http://www.egms.de/de/meetings/rg2010/10rg22.shtml

Published: September 21, 2010

© 2010 Neß.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Any eye medication during pregnancy has a potential risk to the mother and her foetus. Wether ophthalmic medications can be used during pregnancy is a very important issue. The informations of the FDA and the Rote Liste, and the experiences of the German and international pharmacovigilance centers help to find recommendations for the treatment of pregnant patients with eye diseases. Overall the risk of giving ophthalmic drugs to pregnant women is low.